Overview
Matteo Tiberti practices practicing medicine in Copenhagen, Denmark.
His clinical expertise encompasses Acid Sphingomyelinase Deficiency (ASMD) and Niemann-Pick Disease.
He is actively involved in clinical research, co-authoring 42 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Matteo Tiberti
Is Matteo Tiberti a top-rated expert for Acid Sphingomyelinase Deficiency (ASMD)?
MediFind is an objective health platform that identifies experts based on real-world data. Matteo Tiberti is classified as an Experienced expert for Acid Sphingomyelinase Deficiency (ASMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Matteo Tiberti participate in research or clinical trials?
Yes. Matteo Tiberti has published 42 articles and abstracts on conditions like Acid Sphingomyelinase Deficiency (ASMD). You can view a list of Matteo Tiberti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acid Sphingomyelinase Deficiency (ASMD)Mr. Tiberti isExperienced. Learn about Acid Sphingomyelinase Deficiency (ASMD).
- Niemann-Pick DiseaseMr. Tiberti isExperienced. Learn about Niemann-Pick Disease.